Learn More
Medchemexpress LLC 3-[(1S)-1-(dimethylamino)ethyl]phenol | 139306-10-8 | 99.0% | 165.23 g·mol⁻¹ | C10H15NO | 10 G

Supplier: Medchemexpress LLC HYW02057610G
Rivastigmine metabolite (NAP 226-90) is the primary human metabolite of rivastigmine and functions as an acetylcholinesterase (AChE) inhibitor. It is provided as a solid analytical standard with high reported purity and is intended for research use in analytical, pharmacological, and Alzheimer's disease studies.
- Acts as an acetylcholinesterase inhibitor.
- Supplied as a solid, white to off-white standard.
- High reported purity suitable for analytical work.
- Available in multiple pack sizes, including solid and solution formats.
- Suitable as an analytical standard for LC-MS and quantitative assays.
- Intended for use in pharmacology and Alzheimer's disease research.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.